Hypothesis

In aged kidneys, senescent proximal tubule cells release exosomes enriched in specific microRNAs (e.g., miR‑34a‑5p and miR‑21‑3p) that directly inhibit TFEB mRNA translation and stability. This post‑transcriptional blockade works together with mTORC1‑mediated TFEB phosphorylation to lock TFEB in the cytoplasm, thereby actively suppressing autophagy initiation. The resulting autophagy inhibition preserves a damaged proteome and organelle load, which paradoxically supports short‑term cellular viability by avoiding the energetic cost and potential lethal stress of a massive lysosomal clearance.

Mechanistic Rationale

1. Senescent‑cell SASP expands beyond proteins and cytokines – recent work shows that SASP can include nucleic acid cargo in extracellular vesicles ([1]).
2. miR‑34a and miR‑21 are established regulators of TFEB – they bind the 3′‑UTR of TFEB, reducing protein levels and promoting lysosomal dysfunction ([2]).
3. Feedback loop – reduced TFEB diminishes lysosomal biogenesis, leading to accumulation of damaged mitochondria that further amplify SASP production, reinforcing the suppression ([3]).

Testable Predictions

• Prediction 1: Isolation of exosomes from serum or urine of aged mice (or human kidney biopsy supernatants) will show elevated miR‑34a‑5p and miR‑21‑3p levels compared with young controls.
• Prediction 2: In vitro treatment of young proximal tubule cells with exosomes from senescent kidney cells will decrease TFEB protein (without altering mTORC1 activity) and reduce LC3‑II conversion and lysosomal acidification.
• Prediction 3: Pharmacological blockade of exosome release (e.g., with GW4869) or neutralization of miR‑34a/miR‑21 using antagomiRs in aged kidneys will restore TFEB nuclear localization, increase autophagic flux, and alleviate senescence markers despite persistent mTORC1 activity.

Experimental Approach

• Collect urine/exosome fractions from young (3‑month) and aged (24‑month) mice; perform small‑RNA sequencing to quantify miR‑34a‑5p and miR‑21‑3p.
• Culture primary mouse renal proximal tubule cells; induce senescence via doxorubicin or irradiation; harvest exosomes.
• Apply exosomes to naïve cells; assess TFEB levels by western blot, lysosomal localisation by immunofluorescence, autophagy flux via bafilomycin A1‑treated LC3‑II turnover.
• In vivo, administer GW4869 or antagomiR‑34a/antagomiR‑21 via subcutaneous pumps to aged mice for 4 weeks; evaluate kidney histology, p16INK4a expression, lysosomal cathepsin activity, and functional markers (creatinine clearance, albuminuria).

Falsifiability

If exosomal miR‑34a/miR‑21 levels are not elevated in aged kidneys, or if their inhibition fails to rescue TFEB nuclear localisation and autophagic flux, the hypothesis would be refuted. Conversely, a positive outcome would support the notion that autophagy suppression in aging is an actively enforced, paracrine mechanism rather than a passive decline.